WindMIL Therapeutics’ EVP and CSO Kimberly Noonan, VP of Manufacturing Sanjin Zvonic, and VP of Regulatory and Quality Systems Vashi Patel to participate in panels at Phacilitate 2020 in Miami

WindMIL Therapeutics to attend 2020 JP Morgan conference in San Francisco

WindMIL Therapeutics’ Don Hayden, Kim Noonan, Monil Shah, and Patrick Dougherty will be in San Francisco for JPMorgan week to meet with potential and existing investors and partners.

Kimberly Noonan, WindMIL Therapeutics EVP, CSO and Co-Founder to Participate in the 2019 Association for Value-Based Cancer Care Summit

Kimberly Noonan, WindMIL’s EVP, CSO and Co-Founder will participate in the 2019 Association for Value-Based Cancer Care (AVBCC) Summit on Thursday, October 17th at the New York Athletic Club in NYC. Kim will be joining the panel entitled “Tracking the Innovative Value of CAR, T-cell, NK Cell, Gamma Delta Cells, and Gene Editing Therapies”.   

Maryland Tech Council Bio Innovation Conference

Bethesda North Marriott Hotel & Conference Center — Kim Noonan will be participating in the panel “Changing the Landscape for Cell and Gene Therapy”

WindMIL Therapeutics to Present at Cell & Gene Meeting on the Mesa

WindMIL Therapeutics will present at the Cell & Gene Meeting on the Mesa in Carlsbad, CA on October 3rd, 2019.